Thyroid tablets recalled nationwide over potential 'superpotency': FDA

What it is about

Who published it, and when

How it spread - 6 original reports

1. Tue, 25 August 2026

   2 reports
   • The Hill16:10
     Thyroid tablets recalled nationwide over potential 'superpotency': FDA

     Patients taking the affected lot are advised not to discontinue use without first consulting their health care provider.

   • foxbusiness.com19:33first to report
     Thyroid medication recalled nationwide after tablets found to be 'superpotent': FDA

     Vitruvias Therapeutics is recalling one lot of Thyroid Tablets, USP 30 mg, distributed nationwide after testing found the medication could be more potent than intended

2. Wed, 26 August 2026

   3 reports
   • foxla.com00:13
     Thyroid tablets recalled because they may be ‘superpotent’

     A thyroid medicine was recently recalled over fears that it could be superpotent and end up triggering other side effects.

   • bigfrog104.com15:48
     Thyroid Medication Recall Has CNY's Checking Their Cabinets

     Vitruvias Therapeutics Inc. issued a nationwide voluntary recall of Thyroid Tablets USP 30 mg after FDA testing indicated the medication was superpotent, meaning the actual drug dosage exceeded the label's stated strength.

   • goodhousekeeping.com16:56
     FDA Announces Recall of Thyroid Medicine Due to Potential “Super Potency”

     Here’s everything you need to know.

3. Thu, 27 August 2026

   1 report
   • theepochtimes.com17:59
     Most Commonly Prescribed Thyroid Medication Recalled Over Potency Issues: FDA

     An FDA notice said 17 lots of levothyroxine sodium tablets, the second-most commonly prescribed drug in the United States, are under recall.